Abstract
Chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) is a disease characterized by chronic, profound, disabling, and unexplained fatigue. Although it is hypothesized that brain inflammation is involved in the pathophysiology of CFS/ME, there is no direct evidence of neuroinflammation in patients with CFS/ME. Activation of microglia or astrocytes is related to neuroinflammation. 11C-(R)-(2-chlorophenyl)-N-methyl-N-(1-methylpropyl)-3-isoquinoline-carboxamide (11C-(R)-PK11195) is a ligand of PET for a translocator protein that is expressed by activated microglia or astrocytes. We used 11C-(R)-PK11195 and PET to investigate the existence of neuroinflammation in CFS/ME patients. Methods: Nine CFS/ME patients and 10 healthy controls underwent 11C-(R)-PK11195 PET and completed questionnaires about fatigue, fatigue sensation, cognitive impairments, pain, and depression. To measure the density of translocator protein, nondisplaceable binding potential (BPND) values were determined using linear graphical analysis with the cerebellum as a reference region. Results: The BPND values of 11C-(R)-PK11195 in the cingulate cortex, hippocampus, amygdala, thalamus, midbrain, and pons were 45%–199% higher in CFS/ME patients than in healthy controls. In CFS/ME patients, the BPND values of 11C-(R)-PK11195 in the amygdala, thalamus, and midbrain positively correlated with cognitive impairment score, the BPND values in the cingulate cortex and thalamus positively correlated with pain score, and the BPND value in the hippocampus positively correlated with depression score. Conclusion: Neuroinflammation is present in widespread brain areas in CFS/ME patients and was associated with the severity of neuropsychologic symptoms. Evaluation of neuroinflammation in CFS/ME patients may be essential for understanding the core pathophysiology and for developing objective diagnostic criteria and effective medical treatments.
- neuroinflammation
- chronic fatigue syndrome (CFS)
- myalgic encephalomyelitis (ME)
- 11C-(R)-PK11195
- positron emission tomography (PET)
Footnotes
Published online ▪▪▪▪▪▪▪▪▪▪▪▪.
- © 2014 by the Society of Nuclear Medicine and Molecular Imaging, Inc.
In this issue
Jump to section
Related Articles
Cited By...
- Toward a Disease Module for ME/CFS: A Network-Based Gene Prioritization
- The cardiac output - cerebral blood flow relation is abnormal in most ME/CFS patients with a normal heart rate and blood pressure response during a tilt test
- Hypothalamus volumes in adolescent Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Impact of self-reported fatigue and illness duration
- Brain Alterations in COVID Recovered Revealed by Susceptibility-Weighted Magnetic Resonance Imaging
- Involvement of fatigue in the effect of transcranial magnetic stimulation (TMS) on depression following COVID-19 and COVID-19 vaccination: a before-after study
- Plasma cytokine levels reveal deficiencies in IL-8 and gamma interferon in Long-COVID
- No Signs of Neuroinflammation in Women With Chronic Fatigue Syndrome or Q Fever Fatigue Syndrome Using the TSPO Ligand [11C]-PK11195
- The Pandemic Brain: neuroinflammation in healthy, non-infected individuals during the COVID-19 pandemic
- Redox imbalance links COVID-19 and myalgic encephalomyelitis/chronic fatigue syndrome
- Regional microglial activation in the substantia nigra is linked with fatigue in MS
- Myalgic Encephalomyelitis/Chronic Fatigue Syndrome--Metabolic Disease or Disturbed Homeostasis due to Focal Inflammation in the Hypothalamus?
- Cytokine signature associated with disease severity in chronic fatigue syndrome patients
- Inflammation correlates with symptoms in chronic fatigue syndrome
- CNS findings in chronic fatigue syndrome and a neuropathological case report